Exelixis
EXEL
#1361
Rank
C$22.91 B
Marketcap
C$92.49
Share price
-0.12%
Change (1 day)
68.26%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): C$1.44 Billion

According to Exelixis's latest financial reports the company's current earnings are C$2.43 Billion. In 2025 the company made an earning of C$1.31 Billion, an increase over its 2024 earnings that were of C$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.44 B9.72%
2025 C$1.31 B38.08%
2024 C$0.95 B164.69%
2023 C$0.35 B9.89%
2022 C$0.32 B-20.33%
2021 C$0.41 B124.82%
2020 C$0.18 B-67.14%
2019 C$0.55 B-11.94%
2018 C$0.63 B185.09%
2017 C$0.22 B-325.82%
2016 -C$98.12 Million-58.12%
2015 -C$0.24 Billion-37.61%
2014 -C$0.38 Billion9.75%
2013 -C$0.35 Billion65.96%
2012 -C$0.21 Billion-291.63%
2011 C$0.10 B-195.59%
2010 -C$0.12 Billion-42.17%
2009 -C$0.2 Billion-18.98%
2008 -C$0.25 Billion-6.99%
2007 -C$0.26 Billion46.3%
2006 -C$0.18 Billion33.25%
2005 -C$0.14 Billion-30.92%
2004 -C$0.2 Billion44.29%
2003 -C$0.14 Billion12.86%
2002 -C$0.12 Billion22.79%
2001 -C$95.91 Million60.14%
2000 -C$59.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.61 B 2,431.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.65 B 567.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.37 B 893.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.00 B 591.50%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.74 B 642.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.64 B 1,050.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$11.02 B 661.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-C$11.81 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$40.58 Million-102.80%๐Ÿ‡บ๐Ÿ‡ธ USA